NEW DELHI, May 17 (Reuters) - An Indian government panel has
found 26 potential cases of bleeding and clotting after
administration of AstraZeneca Plc's Covishield vaccine,
the health ministry said on Monday.
"There is a very miniscule but definitive risk of
thromboembolic events" after being vaccinated, the data showed.
(Reporting by Krishna N. Das, writing by Tanvi Mehta
Editing by Gareth Jones)